Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ijivanjee
    Junior Member
    • Jun 2011
    • 8

    #1

    Reactions vs. Samples

    I'm sorry, this is a dumb question.

    When a company advertises 96 reactions, does that essentially mean the product can handle 96 samples? I'm speaking in context of target enrichment/DNA capture.
    www.idtdna.com
    [email protected]
  • GW_OK
    Senior Member
    • Sep 2009
    • 411

    #2
    I think it means you can capture something 96 times. You could do 1 sample 96 times or 96 samples 1 time. That's how I would read it.

    Comment

    • ijivanjee
      Junior Member
      • Jun 2011
      • 8

      #3
      So if a product offers 10 reactions with a max size of 2 MB, then I can have 10 samples with 1X coverage on 2 MB OR I can have 1 sample with 10X coverage on 2MB?
      www.idtdna.com
      [email protected]

      Comment

      • GW_OK
        Senior Member
        • Sep 2009
        • 411

        #4
        I don't think coverage comes into it. That's more of a sequencing issue, not capture.
        I would read "10 reactions with a max size of 2 MB" to mean you may capture up to 2MB total 10 times from any number of samples between 1 and 10.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        41 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Working...